Medical Oncology Hematology Consultants, PA — Newark, Delaware

Public research footprint of Medical Oncology Hematology Consultants, PA, compiled from the ClinicalTrials.gov public registry.

297

Registered studies

192

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Carcinoma · Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma · Metastatic Non-Cutaneous Melanoma · Recurrent Melanoma

Recently updated registry entries

NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT06498635 — Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Medical Oncology Hematology Consultants, PA?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.